Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
1.49M
-
Shares change
-
+494K
-
Total reported value, excl. options
-
$264K
-
Value change
-
+$76K
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$0.18
Significant Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q1 2025
29 filings reported holding ERNA - Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share as of Q1 2025.
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.49M shares
of 110M outstanding shares and own 1.35% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (293K shares), Corient Private Wealth LLC (263K shares), TWO SIGMA SECURITIES, LLC (229K shares), CITIGROUP INC (153K shares), Cypress Point Wealth Management, LLC (94.4K shares), Sippican Capital Advisors (80K shares), Vanguard Personalized Indexing Management, LLC (67.6K shares), CITADEL ADVISORS LLC (65.6K shares), Naviter Wealth, LLC (47.3K shares), and HRT FINANCIAL LP (42.5K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.